Development
Molina Healthcare, Inc.
MOH
$296.88
$3.321.13%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 6.41% | 8.68% | 4.07% | 5.62% | 11.10% |
| Total Other Revenue | -100.00% | 5.26% | 5.56% | -45.00% | 0.00% |
| Total Revenue | 6.25% | 8.67% | 4.07% | 5.49% | 11.09% |
| Cost of Revenue | 6.61% | 8.27% | 2.42% | 4.69% | 9.90% |
| Gross Profit | 3.78% | 11.51% | 15.82% | 10.71% | 20.10% |
| SG&A Expenses | 1.91% | 8.57% | 12.16% | 3.50% | 8.64% |
| Depreciation & Amortization | -8.51% | -6.67% | -4.55% | 10.00% | 34.29% |
| Other Operating Expenses | -127.27% | 256.25% | 54.55% | 0.00% | 10.00% |
| Total Operating Expenses | 5.94% | 8.74% | 3.17% | 4.62% | 9.92% |
| Operating Income | 13.88% | 7.16% | 22.71% | 22.31% | 49.53% |
| Income Before Tax | 270.51% | 8.14% | 24.55% | 24.13% | -42.65% |
| Income Tax Expenses | 231.82% | 12.99% | 24.42% | 23.26% | -33.33% |
| Earnings from Continuing Operations | 285.71% | 6.52% | 24.60% | 24.42% | -45.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 285.71% | 6.52% | 24.60% | 24.42% | -45.63% |
| EBIT | 13.88% | 7.16% | 22.71% | 22.31% | 49.53% |
| EBITDA | 10.99% | 5.53% | 19.75% | 21.12% | 47.37% |
| EPS Basic | 287.04% | 6.15% | 24.81% | 25.50% | -45.35% |
| Normalized Basic EPS | 15.57% | 7.77% | 24.77% | 25.21% | 60.16% |
| EPS Diluted | 284.16% | 6.58% | 25.88% | 25.74% | -45.31% |
| Normalized Diluted EPS | 15.57% | 8.51% | 25.63% | 25.63% | 60.16% |
| Average Basic Shares Outstanding | -0.34% | 0.35% | -0.17% | -0.86% | -0.51% |
| Average Diluted Shares Outstanding | -0.34% | -0.34% | -0.86% | -1.19% | -0.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |